At the 2024 Alzheimers Association International Conference, early results showed that people in early stages of Alzheimers who took the GLP-1 drug liraglutide daily for a year lost almost 50 percent less brain volume in key areas tied to memory and thinking
By implementing Agadias smarter prior authorization tools, organizations can gain control over rising costs, improve the quality and consistency of utilization management, and better support members navigating complex treatment decisions
Cagrilintide is the long-acting analog with C20 fatty-acid albumin tether enabling once-weekly dosing for weight management
They start with a 5mg vial for Phase 1 and Phase 2, then transition to 10mg vials once they reach Phase 3
The phase 3 SURMOUNT programme assessed the safety and efficacy of tirzepatide as obesity treatment and the medication has now been approved (November 2023) for chronic weight management by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [46, 47]
The methylcobalamin component stays constant across all doses